Racial Disparities and Medication in Connective Tissue Diseases

This chapter explores the racial distribution in treatment outcomes for connective tissue disease patients, focusing on the risks of overtreatment and undertreatment linked to standardized tests. The discussion highlights the alarming under-utilization of statins among high-risk patients and the need for improved management strategies in addressing comorbidities, particularly in those with rheumatoid arthritis.